These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21890356)

  • 21. Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1H-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia.
    Genin MJ; Bueno AB; Agejas Francisco J; Manninen PR; Bocchinfuso WP; Montrose-Rafizadeh C; Cannady EA; Jones TM; Stille JR; Raddad E; Reidy C; Cox A; Michael MD; Michael LF
    J Med Chem; 2015 Dec; 58(24):9768-72. PubMed ID: 26568144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrazolidine-3,5-dione derivatives as potent non-steroidal agonists of farnesoid X receptor: virtual screening, synthesis, and biological evaluation.
    Deng G; Li W; Shen J; Jiang H; Chen K; Liu H
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5497-502. PubMed ID: 18815030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.
    Swales KE; Korbonits M; Carpenter R; Walsh DT; Warner TD; Bishop-Bailey D
    Cancer Res; 2006 Oct; 66(20):10120-6. PubMed ID: 17047076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists: Part 1.
    Epple R; Russo R; Azimioara M; Cow C; Xie Y; Wang X; Wityak J; Karanewsky D; Gerken A; Iskandar M; Saez E; Martin Seidel H; Tian SS
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4376-80. PubMed ID: 16750626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.
    Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA
    Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
    Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties.
    Richter HG; Benson GM; Bleicher KH; Blum D; Chaput E; Clemann N; Feng S; Gardes C; Grether U; Hartman P; Kuhn B; Martin RE; Plancher JM; Rudolph MG; Schuler F; Taylor S
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1134-40. PubMed ID: 21269824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of physiochemical properties of the tetrahydroazepinoindole series of farnesoid X receptor (FXR) agonists: beneficial modulation of lipids in primates.
    Lundquist JT; Harnish DC; Kim CY; Mehlmann JF; Unwalla RJ; Phipps KM; Crawley ML; Commons T; Green DM; Xu W; Hum WT; Eta JE; Feingold I; Patel V; Evans MJ; Lai K; Borges-Marcucci L; Mahaney PE; Wrobel JE
    J Med Chem; 2010 Feb; 53(4):1774-87. PubMed ID: 20095622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist.
    Feng S; Yang M; Zhang Z; Wang Z; Hong D; Richter H; Benson GM; Bleicher K; Grether U; Martin RE; Plancher JM; Kuhn B; Rudolph MG; Chen L
    Bioorg Med Chem Lett; 2009 May; 19(9):2595-8. PubMed ID: 19328688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The farnesoid X receptor induces very low density lipoprotein receptor gene expression.
    Sirvent A; Claudel T; Martin G; Brozek J; Kosykh V; Darteil R; Hum DW; Fruchart JC; Staels B
    FEBS Lett; 2004 May; 566(1-3):173-7. PubMed ID: 15147890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
    Cariou B
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):685-91. PubMed ID: 19195631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Farnesoid X receptor agonists in biliary tract disease.
    Fiorucci S; Baldelli F
    Curr Opin Gastroenterol; 2009 May; 25(3):252-9. PubMed ID: 19300246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nelumal A, the active principle from Ligularia nelumbifolia, is a novel farnesoid X receptor agonist.
    Epifano F; Genovese S; James Squires E; Gray MA
    Bioorg Med Chem Lett; 2012 May; 22(9):3130-5. PubMed ID: 22472691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, Synthesis, and Biological Evaluation of Novel Nonsteroidal Farnesoid X Receptor (FXR) Antagonists: Molecular Basis of FXR Antagonism.
    Huang H; Si P; Wang L; Xu Y; Xu X; Zhu J; Jiang H; Li W; Chen L; Li J
    ChemMedChem; 2015 Jul; 10(7):1184-99. PubMed ID: 25982493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
    Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of coumestrol on lipid and glucose metabolism as a farnesoid X receptor ligand.
    Takahashi M; Kanayama T; Yashiro T; Kondo H; Murase T; Hase T; Tokimitsu I; Nishikawa J; Sato R
    Biochem Biophys Res Commun; 2008 Aug; 372(3):395-9. PubMed ID: 18457666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and in vitro Profiling of Dual FXR/LTA4H Modulators.
    Schierle S; Brunst S; Helmstädter M; Ebert R; Kramer JS; Steinhilber D; Proschak E; Merk D
    ChemMedChem; 2021 Aug; 16(15):2366-2374. PubMed ID: 33856122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a chemical tool for the orphan nuclear receptor FXR.
    Maloney PR; Parks DJ; Haffner CD; Fivush AM; Chandra G; Plunket KD; Creech KL; Moore LB; Wilson JG; Lewis MC; Jones SA; Willson TM
    J Med Chem; 2000 Aug; 43(16):2971-4. PubMed ID: 10956205
    [No Abstract]   [Full Text] [Related]  

  • 40. Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation.
    Journe F; Laurent G; Chaboteaux C; Nonclercq D; Durbecq V; Larsimont D; Body JJ
    Breast Cancer Res Treat; 2008 Jan; 107(1):49-61. PubMed ID: 17333335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.